1. Unique issues in the development of ‘targeted’ antineoplastic pharmaceutical agents

   • Maurie Markman

   Editor’s Commentary Pages: 235 - 236

2. Web alert

   News Pages: 237 - 238

3. Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancer

   • Brian J. Byrne
   • Jennifer Garst

   OriginalPaper Pages: 241 - 247

4. Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future

   • Rosalyn A. Juergens
   • Julie R. Brahmer

   OriginalPaper Pages: 248 - 254

5. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer

   • Joe Y. Chang
   • H. Helen Liu
   • Ritsuko Komaki

   OriginalPaper Pages: 255 - 259

6. New therapeutic options for mesothelioma

   • Ranjit Kumar MD Goudar

   OriginalPaper Pages: 260 - 265

7. Recombinant human erythropoietin and overall survival

   • Charles L. Loprinzi

   Clinical Trials Report Pages: 269 - 270

8. The cancer anorexia/weight loss syndrome: Therapeutic challenges

   • Karin F. Giordano
   • Aminah Jatoi

   OriginalPaper Pages: 271 - 276

9. Cancer-related fatigue: An update

   • Amit Sood
   • Timothy J. Moynihan

   OriginalPaper Pages: 277 - 282

10. Limb salvage in the skeletally immature patient

    • Valerae O. Lewis

    OriginalPaper Pages: 285 - 292

11. Imatinib resistance in gastrointestinal stromal tumors

    • Lei L. Chen
    • Mahyar Sabripour
    • Robert S. Benjamin

    OriginalPaper Pages: 293 - 299

12. RETRACTED ARTICLE: New drug developments for patients with metastatic soft tissue sarcoma

    • Jörg Thomas Hartmann
    • Shreyaskumar Patel

    OriginalPaper 08 August 2005 Pages: 300 - 306

13. Critical issues in response evaluation on computed tomography: Lessons from the gastrointestinal stromal tumor model

    • Haesun Choi

    OriginalPaper Pages: 307 - 311